Stereotaxis Ducks Investor Suit Over Product Projections

Law360, New York (March 19, 2014, 5:54 PM EDT) -- A Missouri federal judge on Tuesday dismissed a putative shareholder class action against medical device maker Stereotaxis Inc. and some of its officers over optimistic statements and sales projections concerning its flagship cardiovascular catheter control device, ruling the Stereotaxis statements had been forward-looking and nonactionable. 

U.S. District Judge Henry Edward Autrey dismissed the complaint, ruling Stereotaxis' statements about its flagship product Niobe were nonactionable, forward-looking statements protected by the Reform Act's safe harbor provision. Judge Autrey also found the allegations had not shown that Stereotaxis had...
To view the full article, register now.




Case Information

Case Title

Pound v. Stereotaxis, Inc. et al

Case Number



Missouri Eastern

Nature of Suit



Henry E. Autrey

Date Filed

October 7, 2011

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.